Neutral
Evolent Health ( EVH ) Reports Q2 Loss, Misses Revenue Estimates
Evolent Health (EVH) delivered earnings and revenue surprises of -211.11% and -2.86%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?